119 related articles for article (PubMed ID: 12070759)
21. Correlation between anticonvulsant activity and inhibitory action on glial gamma-aminobutyric acid uptake of the highly selective mouse gamma-aminobutyric acid transporter 1 inhibitor 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole and its N-alkylated analogs.
White HS; Sarup A; Bolvig T; Kristensen AS; Petersen G; Nelson N; Pickering DS; Larsson OM; Frølund B; Krogsgaard-Larsen P; Schousboe A
J Pharmacol Exp Ther; 2002 Aug; 302(2):636-44. PubMed ID: 12130726
[TBL] [Abstract][Full Text] [Related]
22. Up-regulation of noradrenaline transporter in response to prolonged exposure to ketamine.
Hara K; Minami K; Ueno S; Toyohira Y; Tsutsui M; Shigematsu A; Yanagihara N
Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):406-12. PubMed ID: 12012027
[TBL] [Abstract][Full Text] [Related]
23. Tramadol inhibits norepinephrine transporter function at desipramine-binding sites in cultured bovine adrenal medullary cells.
Sagata K; Minami K; Yanagihara N; Shiraishi M; Toyohira Y; Ueno S; Shigematsu A
Anesth Analg; 2002 Apr; 94(4):901-6, table of contents. PubMed ID: 11916794
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of the human norepinephrine transporter in intact 293-hNET cells exposed to desipramine.
Zhu MY; Blakely RD; Apparsundaram S; Ordway GA
J Neurochem; 1998 Apr; 70(4):1547-55. PubMed ID: 9523572
[TBL] [Abstract][Full Text] [Related]
25. Blockade of noradrenaline transport abolishes 4-methylthioamphetamine-induced contraction of the rat aorta in vitro.
Quinn ST; Guiry PJ; Schwab T; Keenan AK; McBean GJ
Auton Autacoid Pharmacol; 2006 Oct; 26(4):335-44. PubMed ID: 16968472
[TBL] [Abstract][Full Text] [Related]
26. [Stimulation and inhibition induced by N-ethylmaleimide in hydrolysis of ATP in rat liver mitochondria].
Lofrumento NE; Pavone A; Zanotti F
Boll Soc Ital Biol Sper; 1980 Sep; 56(18):1817-23. PubMed ID: 7236379
[TBL] [Abstract][Full Text] [Related]
27. Ketamine interacts with the noradrenaline transporter at a site partly overlapping the desipramine binding site.
Hara K; Yanagihara N; Minami K; Ueno S; Toyohira Y; Sata T; Kawamura M; Brüss M; Bönisch H; Shigematsu A; Izumi F
Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):328-33. PubMed ID: 9774220
[TBL] [Abstract][Full Text] [Related]
28. Inhibitive effects of Fructus Psoraleae extract on dopamine transporter and noradrenaline transporter.
Zhao G; Li S; Qin GW; Fei J; Guo LH
J Ethnopharmacol; 2007 Jul; 112(3):498-506. PubMed ID: 17555897
[TBL] [Abstract][Full Text] [Related]
29. Modification of cysteine residues by N-ethylmaleimide inhibits annexin II tetramer mediated liposome aggregation.
Singh TK; Liu L
Arch Biochem Biophys; 2000 Sep; 381(2):235-40. PubMed ID: 11032410
[TBL] [Abstract][Full Text] [Related]
30. Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatoma.
Altmann A; Kissel M; Zitzmann S; Kübler W; Mahmut M; Peschke P; Haberkorn U
J Nucl Med; 2003 Jun; 44(6):973-80. PubMed ID: 12791828
[TBL] [Abstract][Full Text] [Related]
31. Identification and characterization of a novel allosteric modulator (SoRI-6238) of the serotonin transporter.
Nandi A; Dersch CM; Kulshrestha M; Ananthan S; Rothman RB
Synapse; 2004 Sep; 53(3):176-83. PubMed ID: 15236350
[TBL] [Abstract][Full Text] [Related]
32. Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation.
Kulkarni SS; Grundt P; Kopajtic T; Katz JL; Newman AH
J Med Chem; 2004 Jun; 47(13):3388-98. PubMed ID: 15189035
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological properties of the naturally occurring Ala(457)Pro variant of the human norepinephrine transporter.
Paczkowski FA; Bönisch H; Bryan-Lluka LJ
Pharmacogenetics; 2002 Mar; 12(2):165-73. PubMed ID: 11875370
[TBL] [Abstract][Full Text] [Related]
34. Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra.
Paris I; Martinez-Alvarado P; Perez-Pastene C; Vieira MN; Olea-Azar C; Raisman-Vozari R; Cardenas S; Graumann R; Caviedes P; Segura-Aguilar J
J Neurochem; 2005 Mar; 92(5):1021-32. PubMed ID: 15715653
[TBL] [Abstract][Full Text] [Related]
35. Tyrosine residue 271 of the norepinephrine transporter is an important determinant of its pharmacology.
Paczkowski FA; Bryan-Lluka LJ
Brain Res Mol Brain Res; 2001 Dec; 97(1):32-42. PubMed ID: 11744160
[TBL] [Abstract][Full Text] [Related]
36. Effects of the sulfhydryl reagent N-ethylmaleimide on reserpine binding to the catecholamine transporter in chromaffin granule membranes.
Deupree JD; Hitchcock JJ
Cell Mol Neurobiol; 1988 Jun; 8(2):217-24. PubMed ID: 3409268
[TBL] [Abstract][Full Text] [Related]
37. Uptake of mIBG and catecholamines in noradrenaline- and organic cation transporter-expressing cells: potential use of corticosterone for a preferred uptake in neuroblastoma- and pheochromocytoma cells.
Bayer M; Kuçi Z; Schömig E; Gründemann D; Dittmann H; Handgretinger R; Bruchelt G
Nucl Med Biol; 2009 Apr; 36(3):287-94. PubMed ID: 19324274
[TBL] [Abstract][Full Text] [Related]
38. The effect of N-ethylmaleimide on the Na(+)-dependent nucleoside transporter (N3) in rabbit choroid plexus.
Washington CB; Brett CM; Wu X; Giacomini KM
J Pharmacol Exp Ther; 1995 Jul; 274(1):110-4. PubMed ID: 7616386
[TBL] [Abstract][Full Text] [Related]
39. Norepinephrine transporter density as a causative factor in alterations in MIBG myocardial uptake in NIDDM model rats.
Kiyono Y; Iida Y; Kawashima H; Ogawa M; Tamaki N; Nishimura H; Saji H
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):999-1005. PubMed ID: 12173012
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of the noradrenaline transporter by interferon-alpha in cultured bovine adrenal medullary cells.
Toyohira Y; Yanagihara N; Minami K; Ueno S; Uezono Y; Tachikawa E; Kondo Y; Kashimoto T; Izumi F
J Neurochem; 1998 Apr; 70(4):1441-7. PubMed ID: 9523560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
